Skip to main content
Clinical Trials/EUCTR2016-001313-24-DE
EUCTR2016-001313-24-DEActive, not recruitingPhase 1

SUbstition of PERioperative Albumin Deficiency Disorders - SUPERADD

Technische Universität München, Fakultät für Medizin0 sites600 target enrollmentStarted: September 5, 2016Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
600

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. patients older than 18 years
  • 2. patients, who voluntarily signed the consent form of the study
  • 3. a. ASA III or IV
  • b. planned high risk surgery: open aortic surgery, open revascularization of lower limbs, esophagectomy, cystectomy, pancreatic surgery, hepatic surgery, thrombectomy/embolectomy, amputation of a limb, replacement of artificial hip or knee joint
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 210
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 390

Exclusion Criteria

  • 1. emergency surgery
  • 2. severe liver cirrhosis (Child Pugh C)
  • 3. terminal renal insufficiency needing renal replacement therapy
  • 4. patients, who have been randomized in SUPERADD before
  • 5. patients having a caregiver in medical affairs
  • 6. patients with contraindications for albumin
  • 7. patients allergic to albumin or substances in the albumin preparation
  • 8. pregnant women
  • 9. breastfeeding women
  • 10. patient with a BMI > 35 kg/m2

Investigators

Sponsor
Technische Universität München, Fakultät für Medizin

Similar Trials

Can the compensation of protein deficits,... | Clinical Trial